BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 2010
View Archived Issues
Latrophilin-3 gene is linked to susceptibility to ADHD and response to stimulant medication
Read More
Scientists convert human fibroblasts directly to multipotent hematopoietic progenitors
Read More
New apoptosis-inducing molecules discovered
Read More
Tryptophan 5-hydroxylase 2 may be new target to treat depression
Read More
Fresolimumab improves symptoms of primary focal segmental glomerulosclerosis in phase I trial
Read More
CXR-1002 shows promising safety and antitumor activity in first-in-human trial in advanced cancer
Read More
Medgenics extends Factor VIII Biopump collaboration
Read More
Novel serotonin 5-HT6 receptor ligands identified by Abbott
Read More
MiStent drug-eluting coronary stent system advances into clinic
Read More
Banyu Pharma presents new antagonists of peptide P518 receptor
Read More
New inhibitors of dual specificity protein kinase TTK patented
Read More
New inhibitors of cell division protein kinase 4 claimed
Read More
Sanofi Pasteur begins phase II trial of ACAM-CDIFF vaccine
Read More
Worldwide rights to pegsiticase acquired by 3SBio from EnzymeRx
Read More
Transgenomic to purchase Clinical Data's diagnostic business
Read More
Merck & Co. reports phase III data on once-daily raltegravir in HIV-1
Read More
IntelGenx acquires rights to INT-0010 formulation of dronabinol
Read More
Hemispherx requests more to resubmit data to FDA for Ampligen NDA in chronic fatigue syndrome
Read More
FDA to review Spectrum Pharma's complete response regarding Fusilev sNDA
Read More
Lilly is recruiting healthy volunteers for first-in-human trial of LY-2979165
Read More
Nymox Pharma secures financing commitment
Read More
Eisai submits MAA for insomnia treatment SEP-190 in Japan
Read More
Thallion and LFB begin phase II trial of Shigamabs in STEC infections
Read More
Sucampo to update Japanese MAA for lubiprostone in chronic idiopathic constipation
Read More
Keryx's short-term phase III trial of Zerenex meets primary endpoints
Read More